In the aforementioned experiment, we found that the IL-2–STAT5 signaling pathway in CD4+ and CD8+ T cells was significantly activated after CTT compared to that in tumor-bearing control mice (Figure 1G,I). The gene discussed is CD4; the disease is neoplasm.